ARTICLE | Company News
Protagen, Novartis deal
January 6, 2017 8:36 PM UTC
Protagen said it used its SeroTag technology to successfully identify predictive and stratification biomarkers, which Novartis will use in the development of an undisclosed autoimmune drug. SeroTag us...